Prevention of TSE (Transmissible Spongiform Encephalopathies) with synthetic peptides: influence on progression of disease
- PMID: 17682882
- DOI: 10.1007/s11259-007-0088-2
Prevention of TSE (Transmissible Spongiform Encephalopathies) with synthetic peptides: influence on progression of disease
Similar articles
-
Transmissible Spongiform Encephalopathy (TSE): vaccinal approach using the hamster model.Vet Res Commun. 2004 Aug;28 Suppl 1:303-6. doi: 10.1023/b:verc.0000045432.41774.57. Vet Res Commun. 2004. PMID: 15372983 No abstract available.
-
Transmissible spongiform encephalopathies: in-vitro evaluation of the therapeutic potentiality of new molecules.Vet Res Commun. 2003 Sep;27 Suppl 1:331-3. doi: 10.1023/b:verc.0000014173.65253.d1. Vet Res Commun. 2003. PMID: 14535423 No abstract available.
-
Inactivation of transmissible spongiform encephalopathy (prion) agents by environ LpH.J Virol. 2004 Feb;78(4):2164-5. doi: 10.1128/jvi.78.4.2164-2165.2004. J Virol. 2004. PMID: 14747583 Free PMC article.
-
The role of antibodies to PrP in the diagnosis of transmissible spongiform encephalopathies.Dev Biol Stand. 1993;80:141-51. Dev Biol Stand. 1993. PMID: 8270104 Review.
-
Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?Acc Chem Res. 2006 Sep;39(9):646-53. doi: 10.1021/ar050068p. Acc Chem Res. 2006. PMID: 16981681 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources